Skip to main content
Premium Trial:

Request an Annual Quote

European Epigenetics Network Seeks New PIs

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – The EpiGeneSys Network of Excellence, which is funded by the EU's 7th Framework Program and focused on advancing epigenetics and systems biology research, is seeking to bring in nine new investigators by offering three-year research grants of €150,000 ($210,000) for each researcher.

The network, which includes 22 scientific teams in the UK and around Europe, will fund young principal investigators within their first three years of independence who will study biological, computational, or engineering science to develop data relevant to the analysis and modeling of epigenetic mechanisms.

Researchers seeking funding are encouraged to focus their studies on acquisition, storage, modeling, and integration of epigenetics data, and on novel visualization and user guide analysis of massive biological datasets. The investigators also should plan to show active involvement in EpiGeneSys activities, at the level of scientific and technological objectives and at the level of dissemination, training, and long-term activities.

Established researchers seeking to contribute to and partake in the EpiGeneSys activities may apply for an associate membership, which will provide open access to meetings, activities, and other benefits.

EpiGeneSys has identified four areas of focus including characterizing the molecular dynamics of epigenetic systems at the single molecule and cell level; linking genotypes to epigenotypes; investigating how environmental, developmental, and metabolic signals act upon the genome; and understanding epigenetic inheritance through replication, mitosis, and meiosis.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.